phenotypeId,phenotypeName,referentConceptId,clinicalDescription,literatureReview,phenotypeNotes
140168000,Psoriasis,140168,"Overview: Most common (~80%) are plaque psoriasis with other major subtypes being guttate psoriasis (acute onset numerous small inflammatory plaques); pustular psoriasis (chronic pustular eruption), erythrodermic psoriasis.Chronic plaque psoriasis is the most common type of psoriasis and is considered the default type of psoriasis when the term psoriasis is used. Presentation: Plaque psoriasis is characterized by well-demarcated, erythematous, scaly silvery skin plaques of the scalp, extensor elbows, knees and gluteal folds. Assessment: Diagnosis is obvious by clinical examination, with rare need for skin biopsy. Plan: topical therapy with emollients and corticosteroids, UV light phototherapy. Systemic therapy may involve methotrexate, cyclosporine, apremilast. Biologics TNS alpha inhibitors (Etanercept, Infliximab, Adalimumab, Certolizumab), IL-17 pathway inhibitors (Secukinumab, Ixekizumab, Broadalumab) and IL-23 inhibitors (Ustekinumab, Guselkumab) are options in moderate to severe plaque psoriasis. Prognosis: Chronic long-term disease that may progress.",,
